Biomarkers in Lung Cancer Screening: Achievements, Promises, and Challenges

Keyphrases

• Lung Cancer Screening 100%
• Clinical Utility 66%
• Molecular Biomarkers 66%
• Development Effort 33%
• Screening Process 33%
• Unmet Medical Need 33%
• Metabolomics 33%
• Artificial Intelligence 33%
• Airway 33%
• MicroRNA 33%
• DNA Methylation (DNAm) 33%
• Autoantibodies 33%
• Developmental Status 33%
• Next-generation Sequencing 33%
• Genetic Predisposition 33%
• Nodule 33%
• Nasal 33%
• Circulating DNA 33%
• RNA-protein Complex 33%
• Cell Imaging 33%
• Cancer Biomarker Discovery 33%
• Screening Setting 33%
• Blood Proteins 33%
• Imaging Genetics 33%
• Circulating Tumor DNA (ctDNA) 33%
• Radiomics 33%
• Emerging Biomarkers 33%
• Protein Profiling 33%
• Sputum Cells 33%
• Lung Cancer Biomarkers 33%
• Molecular Technology 33%
• Exhaled Breath Biomarkers 33%
• Discovery Project 33%
• Complement Fragments 33%

Biochemistry, Genetics and Molecular Biology

• Cancer Screening 100%
• RNA 33%
• MicroRNA 33%
• DNA Methylation 33%
• Next Generation Sequencing 33%
• Cellular Imaging 33%
• Genetic Predisposition 33%
• Breathing 33%
• Metabolomics 33%
• Tumor Marker 33%
• Autoantibodies 33%
• Biomarker Discovery 33%
• Radiomics 33%
• Circulating Tumor DNA 33%
• Imaging Genetics 33%
• Artificial Intelligence 33%
• Blood Proteins 33%